No Result
View All Result
Success American Investors
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Success American Investors
No Result
View All Result
Home Investing

Barratt to buy Redrow in a £2.5Bn deal

by
February 7, 2024
in Investing
0
Barratt to buy Redrow in a £2.5Bn deal
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

Barratt Developments has sealed a monumental £2.5 billion deal to acquire Redrow, propelling itself to the forefront as the nation’s largest housebuilder.

Pending shareholder approval, this merger will fuse the capabilities of both entities, enabling them to construct nearly 23,000 homes across the UK and generate a turnover of £7.5 billion, based on last year’s figures.

Amidst challenges like heightened mortgage rates dampening home sales over the past 18 months, both firms anticipate that this collaboration will fortify their resilience throughout market cycles.

Forecasts suggest that within three years of integration, synergies could slash £90 million from their combined annual costs. Moreover, Redrow shareholders can anticipate a substantial increase in dividend payouts compared to previous years.

The amalgamation aims to leverage the strengths of three distinct brands—Barratt Homes, David Wilson Homes, and Redrow—under one umbrella. Notably, Redrow specializes in premium housing, particularly larger family residences.

Strategically, Barratt envisions integrating premium offerings into selected sites, while Redrow’s portfolio offers opportunities for Barratt or David Wilson Homes.

This all-paper transaction values Redrow at approximately £2.5 billion—a notable 27 per cent premium over its recent stock market valuation. Redrow shareholders stand to receive 1.44 new Barratt shares for each Redrow share they hold.

In early trading, Redrow shares surged by 13.6 per cent, while Barratt shares initially dipped by 5.4 per cent, reflecting market reactions to the deal.

Upon completion, the combined entity, Barratt Redrow, will predominantly be owned by Barratt’s shareholders, maintaining a two-thirds stake, with Redrow investors retaining the remainder.

Leadership roles within the new group will see David Thomas continuing as Chief Executive, with Caroline Silver as Chairperson and Matthew Pratt, Redrow’s current CEO, joining the board and overseeing Redrow’s operations.

David Thomas expressed enthusiasm, calling the merger an “exciting opportunity” to create an exceptional homebuilder delivering high-quality, sustainable homes.

Similarly, Matthew Pratt highlighted the potential to offer a wider range of energy-efficient homes, enhancing their value proposition to customers.

Steve Morgan, Redrow’s founder, endorsed the deal, expressing confidence in the combined entity’s ability to deliver much-needed homes across the UK.

The announcement coincided with Barratt’s release of interim results, reflecting a decline in pre-tax profit and revenue amidst challenging market conditions.

Nevertheless, with the acquisition of Redrow on the horizon, Barratt aims to leverage synergies and strengths to navigate market challenges and continue providing quality homes to customers across the UK.

Read more:
Barratt to buy Redrow in a £2.5Bn deal

Previous Post

Simed Global Introduces Rapid Diagnostic Innovation Outpacing VAR’s Offside Verifications

Next Post

‘Tell Sid’ NatWest sale to start in June

Next Post
‘Tell Sid’ NatWest sale to start in June

‘Tell Sid’ NatWest sale to start in June

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest
Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

February 14, 2024
Idaho Bucks Managed Care Trend

Idaho Bucks Managed Care Trend

December 5, 2023

Last Day to Give in 2023!

December 31, 2023

The Producer Price Index

September 9, 2023

Is Culture Degeneration Biological or Ideological?

0

0

0

0

Is Culture Degeneration Biological or Ideological?

May 24, 2025

Price Controls and Drug Shortages in France: A Textbook Case of the Evils of Interventionism

May 24, 2025

Is Culture Degeneration Biological or Ideological?

May 24, 2025

Price Controls and Drug Shortages in France: A Textbook Case of the Evils of Interventionism

May 24, 2025

Recent News

Is Culture Degeneration Biological or Ideological?

May 24, 2025

Price Controls and Drug Shortages in France: A Textbook Case of the Evils of Interventionism

May 24, 2025

Is Culture Degeneration Biological or Ideological?

May 24, 2025

Price Controls and Drug Shortages in France: A Textbook Case of the Evils of Interventionism

May 24, 2025

Disclaimer: SuccessAmericanInvestors.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.